ACHP Letter to FDA on Direct-to-Consumer Drug Advertising

The Alliance of Community Health Plans (ACHP) sent a letter to FDA Commissioner Dr. Marty Makary calling for increased oversight of direct-to-consumer prescription drug advertising. Lax enforcement in recent decades has caused these ads to blossom, flooding consumers with misleading content and driving up drug spending. ACHP calls on the FDA to ensure promotional claims in ads reflect full clinical evidence to support informed decision-making by patients and clinicians.